Verification of an automated, digital dispensing platform for at-will broth microdilution-based antimicrobial susceptibility testing

Journal of Clinical Microbiology

Volumn 54, Issue 9, 2016, Pages 2288-2293

  Smith, Kenneth P ^a   Kirby, James E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; REPRODUCIBILITY; DRUG EFFECTS; ENTEROBACTERIACEAE; EVALUATION STUDY; HUMAN; LABORATORY AUTOMATION; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTI-BACTERIAL AGENTS; AUTOMATION, LABORATORY; ENTEROBACTERIACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84983591272     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00932-16     Document Type: Article

References (20)

1. Center for Disease Dynamics, Economics and Policy. 2015. State of the world's antibiotics, 2015. CDDEP, Washington, D.C.
2. Bradford PA, Kazmierczak KM, Biedenbach DJ, Wise MG, Hackel M, Sahm DF. 2015. Correlation of-lactamase production and colistin resistance among Enterobacteriaceae isolates from a global surveillance program. Antimicrob Agents Chemother 60:1385-1392. http://dx.doi.org/10 .1128/AAC.01870-15.
3. Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, P.A.
4. Smith KP, Kirby JE. 2016. Validation of a high-throughput screening assay for identification of adjunctive and directly acting antimicrobials targeting carbapenem-resistant Enterobacteriaceae. Assay Drug Dev Technol 14:194-206. http://dx.doi.org/10.1089/adt.2016.701.
5. Clinical and Laboratory Standards Institute. 2016. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. CLSI document M100-S26. Clinical and Laboratory Standards Institute, Wayne, P.A.
6. European Committee on Antimicrobial Susceptibility Testing. 2016. Recommendations for MIC determination of colistin (polymyxin E) as recommended by the joint CLSI-EUCAST Polymyxin Breakpoints Working Group. http://www.eucast.org/fileadmin/src/media/PDFs /EUCAST-files/General-documents/Recommendations-for-MIC-determination-of-colistin-March-2016.pdf.
7. Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. 2009. Cumitech 31A, Verification and validation of procedures in the clinical microbiology laboratory. Coordinating ed, Sharp SE. ASM Press, Washington, D.C.
8. U.S. Food and Drug Administration. 2009. Guidance for industry and FDA. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems. US Food and Drug Administration, Rockville, M.D.
9. European Committee on Antimicrobial Susceptibility Testing. 2016. Breakpoint tables for interpretation of MICs and zone diameters, version 6.0, valid from 2016-01-01. http://www.eucast.org/fileadmin/src/media /PDFs/EUCAST-files/Breakpoint-tables/v-6.0-Breakpoint-table.pdf.
10. Clinical and Laboratory Standards Institute. 2008. User protocol for evaluation of qualitative test performance. CLSI document EP12-A2. Clinical and Laboratory Standards Institute, Wayne, P.A.
11. Deris ZZ, Yu HH, Davis K, Soon RL, Jacob J, Ku CK, Poudyal A, Bergen PJ, Tsuji BT, Bulitta JB, Forrest A, Paterson DL, Velkov T, Li J, Nation RL. 2012. The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 56:5103-5112. http://dx.doi.org/10.1128 /AAC.01064-12.
12. Reference deleted.
13. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x.
14. Hindler JA, Humphries RM. 2013. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 51:1678-1684. http://dx.doi.org/10.1128/JCM .03385-12.
15. Sutherland CA, Nicolau DP. 2014. To add or not to add polysorbate 80: impact on colistin MICs for clinical strains of Enterobacteriaceae and Pseudomonas aeruginosa and quality controls. J Clin Microbiol 52:3810. http: //dx.doi.org/10.1128/JCM.01454-14.
16. Sader HS, Rhomberg PR, Flamm RK, Jones RN. 2012. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn Microbiol Infect Dis 74:412-414. http: //dx.doi.org/10.1016/j.diagmicrobio.2012.08.025.
17. Kerwin BA. 2008. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci 97:2924-2935. http://dx.doi.org/10.1002/jps.21190.
18. Chiaraviglio L, Kirby JE. 2015. High-throughput intracellular antimicrobial susceptibility testing of Legionella pneumophila. Antimicrob Agents Chemother 59:7517-7529. http://dx.doi.org/10.1128/AAC.01248-15.
19. Tecan Inc. 2016. Tecan D300e digital dispenser-specifications. Tecan Inc, Morrisville, N.C.
20. Sharp SE, Miller MB, Hindler J. 2015. Individualized quality control plan (IQCP): is it value-added for clinical microbiology? J Clin Microbiol 53: 3719-3722. http://dx.doi.org/10.1128/JCM.02385-15.